Personalis Inc PSNL.OQ reported a quarterly adjusted loss of 23 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -54 cents. The mean expectation of six analysts for the quarter was for a loss of 28 cents per share. Wall Street expected results to range from -34 cents to -21 cents per share.
Revenue fell 14.6% to $16.80 million from a year ago; analysts expected $15.74 million.
Personalis Inc's reported EPS for the quarter was a loss of 23 cents.
The company reported a quarterly loss of $16.43 million.
Personalis Inc shares had fallen by 22.5% this quarter.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 6% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for Personalis Inc is $8.00
This summary was machine generated from LSEG data February 27 at 10:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2024 | -0.28 | -0.23 | Beat |
Sep. 30 2024 | -0.35 | -0.64 | Missed |
Jun. 30 2024 | -0.37 | -0.24 | Beat |
Mar. 31 2024 | -0.41 | -0.26 | Beat |
Comments